INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Right to try laws and requirements in Kansas. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Have Enacted State Right to Try Laws | do not have state RTT laws | None (no classic Kansas RTT statute identified); see 2025 Kan. SB 250 (individualized only)“approximately 41 states have enacted legislation that addresses investigational drug access by the terminally ill. These states include: Alabama, Alaska, Arizona, Arkansas, California, ... Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana” | Link | 2026-10-09 | medium |
| Enacted Right to Try Laws Before Federal Law | 0 | None (no classic Kansas RTT statute)“approximately 41 states have enacted legislation that addresses investigational drug access by the terminally ill. These states include: Alabama, Alaska, Arizona, Arkansas, California, ... Georgia, Idaho, Illinois, Indiana, Iowa, Kentucky, Louisiana” | Link | 2026-10-09 | medium |
| Require Individualized Manufacturer Approval for RTT | require individualized approval | 2025 Kan. SB 250 (Right to Try for Individualized Treatments Act)“SB 250 Enacting the right to try for individualized treatments act to permit a manufacturer to make an individualized investigative treatment available to a requesting patient. summarize Bill Summary html check_circle Became law without signature”Note: SB 250 became law without the Governor's signature in the 2025 session (conference report adopted Mar 26, 2025). Enrolled text, s. 1(a)(3): 'Individualized investigational treatment' means drugs, biological products or devices unique to and produced exclusively for one patient based on that patient's genetic profile. Kansas was not on the brief's lead list. | Link | 2026-10-09 | high |
| Provide Manufacturer Liability Protection Under RTT | provide liability shield sources differ | 2025 Kan. SB 250, s. 1(j)“This act shall not create a private cause of action against a manufacturer of an individualized investigational drug, biological product or device ... if the manufacturer ... is complying in good faith with the terms of this act and has exercised reasonable care.”Note: Kansas has no classic RTT statute; under the brief's rule that would be FALSE. But Kansas's only RTT-type law (the 2025 individualized-treatment act) has a 'no private cause of action' clause for manufacturers (not an immunity), qualified by good faith and reasonable care. The value depends on whether an individualized-only act counts; best value TRUE if it does, FALSE if only classic RTT counts. | Link | 2026-10-09 | medium |
| Require Insurer Coverage of Investigational Treatments | do not require coverage | 2025 Kan. SB 250, s. 1(d)-(e)“A health plan, third party administrator or governmental agency may provide coverage for the cost of an individualized investigational drug, biological product or device” | Link | 2026-10-09 | high |
View full Kansas profile (all layers) · Report an error on this page